Please ensure Javascript is enabled for purposes of website accessibility

Emergent BioSolutions plans $108M upgrade of Michigan plant

LANSING, Mich. — Drug developer Emergent BioSolutions Inc. says it wants to spend $108 million to upgrade operations in Michigan by 2016.

The Lansing State Journal reports the Rockville-based company wants to build a $9.6 million administration building and spend another $4 million on infrastructure upgrades by next year.

Work could begin soon in Lansing. That would prepare the way for the additional work over the next several years. Those plans include a new warehouse, a science building and other infrastructure improvements the company says are needed in order to recruit and retain employees.

Emergent BioSolutions makes the anthrax vaccine.

The first phase of the Lansing project would take about 18 months. The company has applied for roughly $6.4 million in local brownfield incentives that would reimburse expenses through 2041.